Related Experiment Videos
BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brca1-Chk1 pathway, implicating checkpoint
Shiaw-Yih Lin1, Rekha Rai, Kaiyi Li
1Department of Molecular Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX 77054, USA. sylin@mdanderson.org
Summary
BRIT1 regulates cell cycle checkpoints and DNA repair. Its depletion causes sensitivity to radiation and links to microcephaly disorders by disrupting the ATR-BRCA1-Chk1 pathway.
Area of Science:
- Cell Biology
- Genetics
- Cancer Research
Background:
- BRIT1 (BRCT-repeat inhibitor of hTERT expression) represses human telomerase and is linked to cellular immortalization.
- BRIT1 is identified as MCPH1, a gene mutated in primary microcephaly patients.
Purpose of the Study:
- To investigate the role of BRIT1 in cell cycle regulation and DNA damage response.
- To explore the connection between BRIT1 deficiency, microcephaly, and DNA damage signaling pathways.
Main Methods:
- Depletion of BRIT1 expression in cells.
- Analysis of cell cycle arrest after ionizing radiation (IR).
- Immunofluorescence to detect BRIT1, gamma-H2AX, and nuclear foci.
- Western blotting to assess BRCA1, Chk1, and Nbs1 phosphorylation.
Main Results:
- BRIT1 depletion abolishes IR-induced cell cycle arrest, leading to IR sensitivity.
- BRIT1 forms irradiation-induced nuclear foci colocalizing with gamma-H2AX.
- BRIT1 is essential for BRCA1 expression, Chk1 expression, and Nbs1 phosphorylation.
Conclusions:
- BRIT1 is a crucial regulator of intra-S and G2/M checkpoints, functioning in DNA repair.
- Defects in BRIT1 disrupt the ATR-BRCA1-Chk1 pathway, explaining microcephaly in MCPH1 deficiency.
- BRIT1's role in the ATR-Chk1 pathway is conserved in microcephaly disorders like Seckel syndrome.